|
U.S. News North Carolina Announces Continuation of ADAP Waiting List for New PatientsSeptember 16, 2003 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! North Carolina health officials yesterday announced a continuation of a waiting list for HIV-positive people who wish to obtain antiretroviral drugs through the state's AIDS Drug Assistance Program, the Raleigh News & Observer reports. The "indefinite holding pattern" was announced amid concerns from AIDS advocates that federal funding for such programs is not keeping pace with rising infection rates, especially in the Southern United States, according to the News & Observer (Avery, Raleigh News & Observer, 9/16). The federal-state ADAP program provides free or low-cost medication to low-income HIV-positive individuals who do not qualify for Medicaid or other drug assistance programs. Many state ADAPs are experiencing financial trouble due to high demand for the drugs, soaring prescription costs and state budget shortfalls. Fifteen states currently have waiting lists or access restrictions on their ADAPs (Kaiser Daily HIV/AIDS Report, 9/11). North Carolina's ADAP has some of the country's toughest eligibility requirements, requiring that individuals earn less than $12,000 a year. Other states' income cutoffs range from $17,000 a year to $44,000 a year for an individual. In the past, waiting lists have had negative consequences for both patients and the state health system, according to Steve Sherman, AIDS Policy/ADAP Coordinator with the state Department of Health and Human Services. The waiting lists wear down patients' health and can contribute to higher incidence rates because people who are not on treatment have higher viral levels and therefore a greater change of transmitting HIV. In addition, the state ends up spending more to hospitalize people than it would have spent paying $12,000 a year for their antiretroviral drugs, Sherman said (Raleigh News & Observer, 9/16). New Funding? Back to other news for September 16, 2003
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2003 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved. A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. |
|